Central Vision Care is categorized under Prescription Eyeglasses in Cedarhurst, NY and active since 1988.
Central Vision Care was established in 1988, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Prescription Eyeglasses business, which does work in the B2C market, and is classified as a Prescription Eyeglasses, under code number 4461300 by the NAICS.
If you are seeking more information, feel free to contact Stuart Rappaport, Owner at the company’s single location by writing to 538 Central Avenue, Cedarhurst, New York NY 11516 or by phoning (516) 374-1010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Central Vision Care |
Contact Person: | Stuart Rappaport, Owner |
Address: | 538 Central Avenue, Cedarhurst, New York 11516 |
Phone Number: | (516) 374-1010 |
Website Address: | opticalhouse.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1988 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Prescription Eyeglasses |
SIC Code: | 5995 |
NAICS Code: | 4461300 |
Share This Business: |
Central Vision Care was started in 1988 to provide professional Prescription Eyeglasses under the SIC code 5995 and NAICS code 4461300. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Stuart Rappaport, Owner for inquiries that concern Central Vision Care by calling the company number (516) 374-1010, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Vision Care can be found at the coordinates 40.62234,-73.72294 as well as the street address 538 Central Avenue in Cedarhurst, New York 11516.
For its online presence, you may visit Central Vision Care’s website at opticalhouse.com and engage with its social media outlets through on Twitter and on Facebook.